| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/04/2011 | CN1864822B Separating film for removing carbon monoxide, separating film assembly, method and device, an oxygen carrier with carbon monoxide removed and its pharmaceutical composition |
| 05/04/2011 | CN102046630A Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors |
| 05/04/2011 | CN102046629A Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound |
| 05/04/2011 | CN102046628A Alpha helix mimetics and methods relating thereto |
| 05/04/2011 | CN102046627A GABAA receptor modulators |
| 05/04/2011 | CN102046626A Carba-nucleoside analogs for antiviral treatment |
| 05/04/2011 | CN102046622A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 05/04/2011 | CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102040591A 7-phenyl quinolone compounds |
| 05/04/2011 | CN102040589A Condensed-cyclic compound and organic light emitting diode |
| 05/03/2011 | US7935852 Fluoridation method |
| 05/03/2011 | US7935824 Ethylenediamine derivatives |
| 05/03/2011 | US7935815 Imidazoyl pyridine compounds and salts thereof |
| 05/03/2011 | US7935708 Dihydropyrazolopyrimidinone derivatives |
| 05/03/2011 | US7935702 Substituted biaryl quinolin-4-ylamine analogues |
| 05/03/2011 | US7935695 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | CA2557184C Pyrazolotriazines as kinase inhibitors |
| 05/03/2011 | CA2415010C Propane-1,3-dione derivatives useful as gnrh receptor antagonist |
| 04/29/2011 | CA2741429A1 Process for preparing chlorins and their pharmaceutical uses |
| 04/28/2011 | WO2011050220A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
| 04/28/2011 | WO2011050215A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator |
| 04/28/2011 | WO2011050202A1 Fused heterocyclic compounds as orexin receptor modulators |
| 04/28/2011 | WO2011050198A1 Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
| 04/28/2011 | WO2011050068A2 Bivalent diazo bicyclic smac mimetics and the uses thereof |
| 04/28/2011 | WO2011050016A1 Akt inhibitors |
| 04/28/2011 | WO2011049531A1 N-type materials and organic electronic devices |
| 04/28/2011 | WO2011049344A2 Method of preparing sitagliptin and intermediates used therein |
| 04/28/2011 | WO2011049063A1 Organic electroluminescent element |
| 04/28/2011 | WO2011048611A1 Novel fused pyridazine derivatives |
| 04/28/2011 | WO2011048111A1 Compounds |
| 04/28/2011 | WO2011048082A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011017334A3 Mesoionic pesticides |
| 04/28/2011 | US20110098471 Oxazolidinone derivative having fused ring |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098327 Hepatitis C Virus Inhibitors |
| 04/28/2011 | US20110098307 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 04/28/2011 | US20110098279 Use of triazolopyrimidine derivatives as microbicides |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098268 Spirocyclic compounds |
| 04/28/2011 | US20110098262 Corroles for neuroprotection and neurorescue |
| 04/28/2011 | CA2778493A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
| 04/28/2011 | CA2778492A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator |
| 04/28/2011 | CA2778484A1 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| 04/28/2011 | CA2778291A1 Akt inhibitors |
| 04/28/2011 | CA2777902A1 Compounds |
| 04/28/2011 | CA2777881A1 Pyrazolopyrimidine derivatives |
| 04/28/2011 | CA2776407A1 Method of preparing sitagliptin and intermediates used therein |
| 04/28/2011 | CA2775009A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| 04/27/2011 | EP2315502A1 Electroluminescent device |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314571A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 04/27/2011 | EP2313415A2 Pyromellitic diimide organic semiconductors and devices |
| 04/27/2011 | EP2313414A2 Kinase inhibitors and methods of use |
| 04/27/2011 | EP2313413A1 Pyrazolo [1, 5-a] pyrimidine derivatives |
| 04/27/2011 | EP2313412A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof |
| 04/27/2011 | EP2313411A1 5h-pyrr0l0 [2,3-b]pyrazine derivatives for kinase modulation, and indications therefor |
| 04/27/2011 | EP2313410A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
| 04/27/2011 | EP2313407A1 cMET INHIBITORS |
| 04/27/2011 | EP2312951A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 04/27/2011 | EP2312948A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 04/27/2011 | EP2312947A1 Trpv4 antagonists |
| 04/27/2011 | EP1951724B1 FUSED BICYCLIC mTOR INHIBITORS |
| 04/27/2011 | EP1709052B1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1406905B1 Water- and organic-soluble cucurbituril derivatives, their preparation methods, their separation methods and uses |
| 04/27/2011 | CN102036996A Bridged heterocycles as HIV integrase inhibitors |
| 04/27/2011 | CN102036992A Switchable special effect substances |
| 04/27/2011 | CN102036991A GPR119 receptor agonists |
| 04/27/2011 | CN102036990A Novel tyrosine kinase inhibitors |
| 04/27/2011 | CN102036986A Conversion of tryptophan into beta-carboline derivatives |
| 04/27/2011 | CN102030755A Method for preparing high-purity triethylene diamine |
| 04/27/2011 | CN102030701A Fluoradene derivative and preparation method thereof |
| 04/27/2011 | CN101591295B Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof |
| 04/27/2011 | CN101538269B Recovery method for dealcoholizing waste water in glycine technology of chloroactic acid method |
| 04/27/2011 | CN101418001B Dipeptidase-IV inhibitor sulfonyl urea derivates |
| 04/27/2011 | CN101397300B Dipeptidase-IV inhibitor derivates |
| 04/27/2011 | CN101239942B Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same |
| 04/27/2011 | CN101092417B Folacin analogue, and salt of folacin analogue in use for medical treatment |
| 04/26/2011 | US7932384 Reverse-turn mimetics and method relating thereto |
| 04/26/2011 | US7932383 Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 04/26/2011 | US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 04/26/2011 | US7932261 Macrocycle derivatives useful as inhibitors of β-secretase (BACE) |
| 04/26/2011 | US7932260 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7932257 Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors |
| 04/26/2011 | US7932253 Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 04/26/2011 | US7932250 Thienopyrazole derivative having PDE7 inhibitory activity |
| 04/26/2011 | US7932248 3-(1,4-Diazabicyclo[3.2.2]non-4-ylcarbonyl)-5-(tetrahydro-2H-pyran-4-yloxy)-1H-indazole,nicotinic receptor agonists; particularly ligands for the nicotinic alpha-7-receptor(alpha 7 nAChR subtype); brain disorders; neuroprotectants; strokes; antiischemic agents; glutamate-induced excitotoxicity |
| 04/26/2011 | US7932247 M3 muscarinic acetylcholine receptor antagonists |
| 04/26/2011 | US7932246 Histone deacetylase inhibitors |
| 04/26/2011 | CA2500952C Neurologically-active compounds |
| 04/26/2011 | CA2495879C Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2462657C Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |